OptimizeRx (OPRX) Retained Earnings: 2010-2025
Historic Retained Earnings for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to -$84.3 million.
- OptimizeRx's Retained Earnings rose 4.03% to -$84.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.3 million, marking a year-over-year increase of 4.03%. This contributed to the annual value of -$84.4 million for FY2024, which is 3129.57% down from last year.
- Per OptimizeRx's latest filing, its Retained Earnings stood at -$84.3 million for Q3 2025, which was up 4.03% from -$85.0 million recorded in Q2 2025.
- In the past 5 years, OptimizeRx's Retained Earnings registered a high of -$35.3 million during Q4 2021, and its lowest value of -$86.6 million during Q1 2025.
- In the last 5 years, OptimizeRx's Retained Earnings had a median value of -$57.3 million in 2023 and averaged -$59.1 million.
- Per our database at Business Quant, OptimizeRx's Retained Earnings soared by 300.57% in 2021 and then tumbled by 4021.1% in 2024.
- OptimizeRx's Retained Earnings (Quarter) stood at -$35.3 million in 2021, then plummeted by 32.45% to -$46.7 million in 2022, then plummeted by 37.62% to -$64.3 million in 2023, then plummeted by 31.3% to -$84.4 million in 2024, then rose by 0.13% to -$84.3 million in 2025.
- Its last three reported values are -$84.3 million in Q3 2025, -$85.0 million for Q2 2025, and -$86.6 million during Q1 2025.